Literature DB >> 15962093

Regulation of endothelial derived nitric oxide in health and disease.

William C Sessa1.   

Abstract

Endothelial nitric oxide synthase (eNOS) is the primary physiological source of nitric oxide (NO) that regulates cardiovascular homeostasis. Historically eNOS has been thought to be a constitutively expressed enzyme regulated by calcium and calmodulin. However, in the last five years it is clear that eNOS activity and NO release can be regulated by post-translational control mechanisms (fatty acid modification and phosphorylation) and protein-protein interactions (with caveolin-1 and heat shock protein 90) that direct impinge upon the duration and magnitude of NO release. This review will summarize this information and apply the post-translational control mechanisms to disease states.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962093     DOI: 10.1590/s0074-02762005000900004

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  33 in total

1.  Caveolin-1 mediates endotoxin inhibition of endothelin-1-induced endothelial nitric oxide synthase activity in liver sinusoidal endothelial cells.

Authors:  Willson Kwok; Sang Ho Lee; Cathy Culberson; Katarzyna Korneszczuk; Mark G Clemens
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

2.  Rate, affinity and calcium dependence of nitric oxide synthase isoform binding to the primary physiological regulator calmodulin.

Authors:  Jonathan L McMurry; Carol A Chrestensen; Israel M Scott; Elijah W Lee; Aaron M Rahn; Allan M Johansen; Brian J Forsberg; Kyle D Harris; John C Salerno
Journal:  FEBS J       Date:  2011-11-11       Impact factor: 5.542

3.  Simulated microgravity perturbs actin polymerization to promote nitric oxide-associated migration in human immortalized Eahy926 cells.

Authors:  Jamila H Siamwala; S Himabindu Reddy; Syamantak Majumder; Gopi Krishna Kolluru; Ajit Muley; Swaraj Sinha; Suvro Chatterjee
Journal:  Protoplasma       Date:  2010-02-20       Impact factor: 3.356

4.  CYP1B1 and endothelial nitric oxide synthase combine to sustain proangiogenic functions of endothelial cells under hyperoxic stress.

Authors:  Yixin Tang; Elizabeth A Scheef; Zafer Gurel; Christine M Sorenson; Colin R Jefcoate; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-23       Impact factor: 4.249

Review 5.  Endothelial dysfunction: a strategic target in the treatment of hypertension?

Authors:  Eva H C Tang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-02-02       Impact factor: 3.657

Review 6.  Mitochondria and endothelial function.

Authors:  Matthew A Kluge; Jessica L Fetterman; Joseph A Vita
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

7.  Decreased endothelial nitric oxide synthase expression and function contribute to impaired mitochondrial biogenesis and oxidative stress in fetal lambs with persistent pulmonary hypertension.

Authors:  Adeleye J Afolayan; Annie Eis; Maxwell Alexander; Teresa Michalkiewicz; Ru-Jeng Teng; Satyan Lakshminrusimha; Girija G Konduri
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-30       Impact factor: 5.464

8.  Regulation of FMN subdomain interactions and function in neuronal nitric oxide synthase.

Authors:  Robielyn P Ilagan; Jesús Tejero; Kulwant S Aulak; Sougata Sinha Ray; Craig Hemann; Zhi-Qiang Wang; Mahinda Gangoda; Jay L Zweier; Dennis J Stuehr
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

9.  Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation.

Authors:  Xiangbin Xu; Bong Sook Jhun; Chang Hoon Ha; Zheng-Gen Jin
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

10.  Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells.

Authors:  Cleide Gonçalves da Silva; Anke Specht; Barbara Wegiel; Christiane Ferran; Elzbieta Kaczmarek
Journal:  Circulation       Date:  2009-02-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.